Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

To Evaluate the Clinical Utility of Specific Autoantibody Testing in Patients With Interstitial Lung Disease

NCT01600352 is registered in ClinicalTrials.gov with Singapore General Hospital as lead sponsor.

NCT NCT01600352
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01600352 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
To Evaluate the Clinical Utility of Specific Autoantibody Testing in Patients With Interstitial Lung Disease
Lead sponsor
Singapore General Hospital
Phase
Observational
Overall status
Completed
Start date
May 31, 2012
Completion date
April 30, 2017
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

interstitial lung disease